Browsing Tag
ENT
2 posts
Smith+Nephew Q3 2025: Can the CATALYSTEM rollout and REGENETEN momentum offset VBP risks?
Smith+Nephew raises 2025 free cash flow guidance to USD 750 million as margin growth accelerates. Find out what’s driving the company’s transformation.
November 7, 2025
Laryngitis explained: How inflammation of the voice box affects vocal health and treatment options
Learn what causes laryngitis, how it affects your voice, and the best ways to treat and prevent acute and chronic laryngeal inflammation.
July 13, 2025